<unk>  is an antitubercular drug that is FDA approved for the treatment of pulmonary tuberculosis, in combination with other antituberculosis agents, as second-line therapy. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include drug-induced eosinophilia, Ototoxicity, raised serum blood urea nitrogen.
Capreomycin sulfate
Paromomycin sulfate
Silver sulfadiazine
Lincomycin Hydrochloride
Oxytetracycline hydrochloride
Diloxanide furoate
Amikacin sulfate
Clindamycin phosphate 